Grape King Bio Ltd (葡萄王) yesterday said its Chinese unit, Shanghai Grape King Enterprises Corp (上海葡萄王), has performed sluggishly this year, posting a double-digit decline in sales to about NT$705 million (US$23.11 million) in the first 10 months.
The supplier of probiotics and mycelium health foods had expected the Chinese unit to post 50 percent annual growth in sales, Grape King Bio chairman Andrew Tseng (曾盛麟) told a media briefing in Taoyuan.
Shanghai Grape King was affected by lower orders from two of its major clients in China amid a slowing market dragged by stricter marketing regulations and falling consumer spending due to a US-China trade dispute, Tseng said.
Photo: Kao Shih-ching, Taipei Times
The unit mainly manufactures beauty drinks, such as those containing collagen, for corporate clients.
“Chinese customers are willing to spend on health foods, but they are reducing their spending due to uncertainty about economic development,” Tseng said.
Sales in China have posted annual declines every month since April, with third-quarter sales falling more than 50 percent from a year earlier, Tseng said.
The company expects its Chinese business to recover in the second quarter of next year due to a low comparison base and its diversification strategy.
It aims to gain 10 new clients with possible orders of more than 10 million yuan (US$1.42 million) each next year, Tseng said.
Shanghai Grape King would also begin offering probiotics next year to diversify its product range, he added.
In contrast, Grape King’s business at home remained rosy, posting a double-digit growth in sales in the first 10 months, while its direct-sales subsidiary, Pro-Partner Inc (葡眾), reported that sales rose 5 percent annually, Tseng said.
With a new plant in Taoyuan’s Longtan District (龍潭) beginning operations in July to supply more probiotic products, the firm’s Taiwanese business is expected to remain strong next year, he said.
Grape King has partnered with Uni-President Enterprises Corp’s (統一企業) distribution subsidiary to market more of its health food products, such as Come Best tonic drink, at President Chain Store Corp ( 統一超商) stores and drugstore chain Cosmed (康是美), Tseng said.
Meanwhile, GK Bio International Sdn Bhd, a joint venture by Grape King and Malaysia-based All Cosmos Bio-Tech Holding Corp (全宇生技控股), would begin marketing Grape King’s products next year after gaining approval from Malaysian authorities, Tseng said.
Overall, the company reported that consolidated revenue inched up 0.07 percent annually to NT$7.32 billion in the first 10 months, while net profit fell 1 percent annually to NT$880 million in the first three quarters.
Earnings per share totaled NT$6.49, compared with NT$6.57 last year, company data showed.
Taiwan’s foreign exchange reserves hit a record high at the end of last month, surpassing the US$600 billion mark for the first time, the central bank said yesterday. Last month, the country’s foreign exchange reserves rose US$5.51 billion from a month earlier to reach US$602.94 billion due to an increase in returns from the central bank’s portfolio management, the movement of other foreign currencies in the portfolio against the US dollar and the bank’s efforts to smooth the volatility of the New Taiwan dollar. Department of Foreign Exchange Director-General Eugene Tsai (蔡炯民)said a rate cut cycle launched by the US Federal Reserve
Handset camera lens maker Largan Precision Co (大立光) on Sunday reported a 6.71 percent year-on-year decline in revenue for the third quarter, despite revenue last month hitting the highest level in 11 months. Third-quarter revenue was NT$17.68 billion (US$581.2 million), compared with NT$18.95 billion a year earlier, the company said in a statement. The figure was in line with Yuanta Securities Investment Consulting Co’s (元大投顧) forecast of NT$17.9 billion, but missed the market consensus estimate of NT$18.97 billion. The third-quarter revenue was a 51.44 percent increase from NT$11.67 billion in the second quarter, as the quarter is usually the peak
The US government on Wednesday sanctioned more than two dozen companies in China, Turkey and the United Arab Emirates, including offshoots of a US chip firm, accusing the businesses of providing illicit support to Iran’s military or proxies. The US Department of Commerce included two subsidiaries of US-based chip distributor Arrow Electronics Inc (艾睿電子) on its so-called entity list published on the federal register for facilitating purchases by Iran’s proxies of US tech. Arrow spokesman John Hourigan said that the subsidiaries have been operating in full compliance with US export control regulations and his company is discussing with the US Bureau of
Pegatron Corp (和碩), a key assembler of Apple Inc’s iPhones, on Thursday reported a 12.3 percent year-on-year decline in revenue for last quarter to NT$257.86 billion (US$8.44 billion), but it expects revenue to improve in the second half on traditional holiday demand. The fourth quarter is usually the peak season for its communications products, a company official said on condition of anonymity. As Apple released its new iPhone 17 series early last month, sales in the communications segment rose sequentially last month, the official said. Shipments to Apple have been stable and in line with earlier expectations, they said. Pegatron shipped 2.4 million notebook